Hematopoietic Stem Cell Transplant Survivors Study
NCT02652052
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Stem Cell Transplant
Interventions
OTHER:
Standard of Care - Observation Only
DRUG:
Group 2: Quercetin
DRUG:
Group 2: Dasatinib
Sponsor
Mayo Clinic